UNIverse - Public Research Portal

My research interests

Use of imaging methods (Optical Coherence Tomography, OCT and magnetic resonance imaging, MRI) to understand and quantify neurodegenerative processes in neuroinflammatory diseases
Development of patient-friendly retinal markers of progression in multiple sclerosis (MS) and other neurological diseases
Investigation of the visual pathway as a model of neurodegeneration
Migraine and central pain (imaging and other biomarkers, treatment response)

Selected Publications

Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kuhle, Jens, & Papadopoulou, Athina. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760

URLs

URLs

Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Kuhle J, Granziera C, & Papadopoulou A. (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8

URLs

URLs

Papadopoulou A, Oertel FC, Chien C, Kuchling J, Zimmermann HG, Siebert N, Motamedi S, Souza M, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, & Brandt AU. (2021). Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. NeuroImage: Clinical, 30, 102608. https://doi.org/10.1016/j.nicl.2021.102608

URLs

URLs

Papadopoulou A, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, & Magon S. (2019). Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway. Neurology, 92(19), E2240–E2249. https://doi.org/10.1212/wnl.0000000000007450

URLs

URLs

Selected Projects & Collaborations

Project cover

Eye as window to the brain: Retinal markers of progression in multiple sclerosis

Research Project | 5 Project Members

Multiple sclerosis (MS) is a disease of the central nervous system (CNS), with inflammatory and neurodegenerative components. Most sufferers experience progressive neurological deterioration (“progression”) over the course of the disease, which can significantly impair their quality of life. There is an urgent need for accurate/early markers of progression in MS.

The retina of the eye offers fascinating possibilities in this regard: it is often affected early during the course of MS and it is the only part of the CNS that is easily accessible to us, using non-invasive imaging techniques (through the pupils).

With this project we investigate retinal changes and the value of different retinal markers to predict progression in MS. We will assess the following markers: i) thinning of retinal axons and neurons, ii) stability of fixation and iii) changes in the diameters of retinal vessels. All markers are non-invasive and quick/patient-friendly; they capture different pathophysiological proccesses that probably contribute to progression of disability in MS.

Our study aims at a better understanding of the mechanisms of progression in people with MS and to the early identification of patients at risk. The latter is very important, not only for therapeutic decisions in clinical practice (patient stratification), but also for studies with new, potentially neuroprotective therapies.